tirzepatide approved in canada — 10 mg Zepbound has been approved!, There

It is theorized that patients who are taking a GLP-1 agonist are at a greater risk for pancreatitis due to the medication causing an increase in stimulation of GLP-1 receptors located in the pancreas

GLP-1 medications are not recommended during breastfeeding because limited data exists on whether these compounds pass into breast milk and what effects they might have on a nursing infant

However, the Oxford researchers admitted the science is solid on glutathione and NACs ability to combat oxidative stress and inflammation associated with active viral infections, including influenza A

Accessed January 8, 2026.

doi: 10.1016/j.gene.2021.145619 26